Evidence map›Paper›PMID 26612049›Full record

SynthesisLipids in health and disease2015

Adiponectin is associated with poor prognosis in carcinoma patients: evidence from a meta-analysis.

Jiaxiang Ye, Zhongguo Liang, Qian Liang, Jinyan Zhang, Sufei Mao, Rui Liang

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Lipids in health and disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jiaxiang YeDepartment of Medical Oncology, The Cancer Institute, Affiliated Tumor Hospital of Guangxi Medical University, No. 71, Hedi Road, Nanning, Guangxi, 530021, P.R. China. yejiaxiang2013@163.com.
Zhongguo LiangDepartment of Medical Oncology, The Cancer Institute, Affiliated Tumor Hospital of Guangxi Medical University, No. 71, Hedi Road, Nanning, Guangxi, 530021, P.R. China.
Qian LiangGraduate School of Guangxi Medical University, Nanning, Guangxi, 530021, P.R. China.
Jinyan ZhangDepartment of Medical Oncology, The Cancer Institute, Affiliated Tumor Hospital of Guangxi Medical University, No. 71, Hedi Road, Nanning, Guangxi, 530021, P.R. China.
Sufei MaoDepartment of Medical Oncology, The Cancer Institute, Affiliated Tumor Hospital of Guangxi Medical University, No. 71, Hedi Road, Nanning, Guangxi, 530021, P.R. China.
Rui LiangDepartment of Anesthesiology, The Cancer Institute, Affiliated Tumor Hospital of Guangxi Medical University, No. 71, Hedi Road, Nanning, Guangxi, 530021, P.R. China. liangrui011@126.com.
Tumor Hospital of Guangxi Medical University · CNGuangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStudies have come to conflicting conclusions about whether adiponectin (APN) expression is associated with cancer prognosis. To help resolve this question, we meta-analyzed the available evidence.

methodsPubMed, EMBASE, the Cochrane Library, the Chinese Biological Medical Database and the Chinese National Knowledge Infrastructure Database were systematically searched to identify all eligible studies examining APN expression and prognosis for patients with any type of cancer. Pooled hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) related to overall survival (OS) or disease-free survival (DFS) were calculated.

resultsTen studies involving 999 patients were meta-analyzed. Analysis across all patients revealed no significant association between high/positive APN expression and DFS, but they did show a significant association between high/positive APN expression and OS (HR 1.51, 95 %CI 1.21 to 1.89). Subgroup analysis showed that high/positive APN expression in non-Asians was significantly associated with both DFS (HR 1.36, 95% CI 1.03 to 1.80) and OS (HR 1.53, 95 %CI 1.20 to 1.96), but no such associations were observed in Asians. In addition, high/positive APN expression was significantly associated with OS across all patients with hepatocellular carcinoma (HR 1.89, 95 %CI 1.20 to 2.98).

conclusionsThe available evidence suggests that high/positive APN expression is associated with poor prognosis for patients with various carcinomas, especially for non-Asian cancer patients and for all patients with hepatocellular carcinoma. These findings should be confirmed and extended in large, well-designed studies.

Indexed as

AdiponectinBiomarkers, TumorDisease-Free SurvivalHumansKaplan-Meier EstimateMultivariate AnalysisNeoplasmsProportional Hazards ModelsAdiponectinBiomarkers, Tumor

Identifiers

PMID26612049
PMCPMC4661958
OpenAlexW2176426099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.